# Editorial: Current trends in immunotherapy: from monoclonal antibodies to CAR-T cells

**Authors:** Kishor Pant, Mark C. Glassy

PMC · DOI: 10.3389/fmmed.2025.1633469 · Frontiers in Molecular Medicine · 2025-06-02

## Full-text entities

- **Genes:** HLA-C (major histocompatibility complex, class I, C) [NCBI Gene 3107] {aka D6S204, HLA-JY3, HLAC, HLC-C, MHC, PSORS1}, TRBV20OR9-2 (T cell receptor beta variable 20/OR9-2 (non-functional)) [NCBI Gene 6962] {aka CDR3, TCRBV20S2, TCRBV2O, TCRBV2S2O}
- **Diseases:** haematologic and solid tumours (MESH:D009369), toxicities (MESH:D064420), non (MESH:C580335), non-small cell lung cancer (MESH:D002289), melanoma (MESH:D008545), oncologic disorders (MESH:D000072716), renal cell carcinoma (MESH:D002292)
- **Chemicals:** Chimeric antigen (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12171432/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12171432/full.md

## References

8 references — full list in the complete paper: https://tomesphere.com/paper/PMC12171432/full.md

---
Source: https://tomesphere.com/paper/PMC12171432